# Notice Pursuant to the National Cooperative Research and Production Act of 1993—International Pharmaceutical Aerosol Consortium for Toxicology Testing of HFA-227 (IPACT-II)
Notice is hereby given that, on June 13, 2002, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 *et seq.* (the “Act”), the International Pharmaceutical Aerosol Consortium for Toxicololgy Testing of HFA-227 (IPACT-II) filed written notifications simultaneously with the Attorney General and the Federal Trade Commission announcing the termination of IPACT-II, effective April 30, 2001.
Although membership in IPACT-II is no longer open, the data that IPACT-II generated oin HFA-227 will continue to be available through a cost-sharing license.
On February 21, 1991, IPACT-II filed its original notification pursuant to 15 U.S.C. 4305(a). The Department of Justice published a notice in the *Federal Register* pursuant to 15 U.S.C. 4305(b) on April 2, 1991 (56 FR 13489).
The last notification was filed with the Department on March 15, 2000. The Department of Justice published a notice in the *Federal Register* pursuant to 15 U.S.C. 4305(b) on August 17, 2000 (65 FR 20218).
Constance K. Robinson,
Director of Operations, Antitrust Division.